
Aldeyra The is a biotechnology business based in the US. Aldeyra The shares (ALDX) are listed on the NASDAQ and all prices are listed in US Dollars. Aldeyra The employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Aldeyra The stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ALDX. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Aldeyra The stock price (NASDAQ: ALDX)
Use our graph to track the performance of ALDX stocks over time.Aldeyra The shares at a glance
Latest market close | $6.09 |
---|---|
52-week range | $2.36 - $7.99 |
50-day moving average | $6.14 |
200-day moving average | $5.18 |
Wall St. target price | $19.88 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-1.11 |
Buy Aldeyra The stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Aldeyra The stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aldeyra The price performance over time
Historical closes compared with the close of $6.09 from 2023-01-27
1 week (2023-01-24) | 0.50% |
---|---|
1 month (2022-12-30) | -12.50% |
3 months (2022-10-31) | 11.54% |
6 months (2022-07-29) | 20.83% |
1 year (2022-01-27) | 86.81% |
---|---|
2 years (2021-01-29) | -45.63% |
3 years (2020-01-31) | 14.04% |
5 years (2018-01-30) | 7.575 |
Aldeyra The financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -18.42% |
Return on equity TTM | -33.98% |
Profit margin | 0% |
Book value | $2.77 |
Market capitalisation | $353.1 million |
TTM: trailing 12 months
Aldeyra The share dividends
We're not expecting Aldeyra The to pay a dividend over the next 12 months.
Aldeyra The share price volatility
Over the last 12 months, Aldeyra The's shares have ranged in value from as little as $2.355 up to $7.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aldeyra The's is 1.143. This would suggest that Aldeyra The's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Aldeyra The overview
Aldeyra Therapeutics, Inc. , a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma. The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc.
Aldeyra The in the news
Insiders made the right call by buying US$1.2m Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) stock this year, currently sit on US$349k profit
Frequently asked questions
What percentage of Aldeyra The is owned by insiders or institutions?Currently 2.349% of Aldeyra The shares are held by insiders and 64.904% by institutions. How many people work for Aldeyra The?
Latest data suggests 15 work at Aldeyra The. When does the fiscal year end for Aldeyra The?
Aldeyra The's fiscal year ends in December. Where is Aldeyra The based?
Aldeyra The's address is: 131 Hartwell Avenue, Lexington, MA, United States, 02421 What is Aldeyra The's ISIN number?
Aldeyra The's international securities identification number is: US01438T1060 What is Aldeyra The's CUSIP number?
Aldeyra The's Committee on Uniform Securities Identification Procedures number is: 01438T106
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert